These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 25641338)

  • 1. CXCL1 promotes tumor growth through VEGF pathway activation and is associated with inferior survival in gastric cancer.
    Wei ZW; Xia GK; Wu Y; Chen W; Xiang Z; Schwarz RE; Brekken RA; Awasthi N; He YL; Zhang CH
    Cancer Lett; 2015 Apr; 359(2):335-43. PubMed ID: 25641338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of activated signal transducer and activator of transcription 3 predicts expression of vascular endothelial growth factor in and angiogenic phenotype of human gastric cancer.
    Gong W; Wang L; Yao JC; Ajani JA; Wei D; Aldape KD; Xie K; Sawaya R; Huang S
    Clin Cancer Res; 2005 Feb; 11(4):1386-93. PubMed ID: 15746037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Epigallocatechin-3-gallate inhibits growth and angiogenesis of gastric cancer and its molecular mechanism].
    Zhu BH; Zhan WH; He YL; Cai SR; Wang Z; Zhang CH
    Zhonghua Wei Chang Wai Ke Za Zhi; 2009 Jan; 12(1):82-5. PubMed ID: 19145512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C-X-C motif chemokine receptor 4 promotes tumor angiogenesis in gastric cancer via activation of JAK2/STAT3.
    Zhang Q; Xu F; Shi Y; Chen YW; Wang HP; Yu X; Li Y
    Cell Biol Int; 2017 Aug; 41(8):854-862. PubMed ID: 28544312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TRIM59 is up-regulated in gastric tumors, promoting ubiquitination and degradation of p53.
    Zhou Z; Ji Z; Wang Y; Li J; Cao H; Zhu HH; Gao WQ
    Gastroenterology; 2014 Nov; 147(5):1043-54. PubMed ID: 25046164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of JAK2/STAT3 signaling pathway on angiogenesis in non-small cell lung cancer].
    Zhao M; Liu F; Wang JY; Zhang WY; Gao FH; Jiang B
    Zhonghua Yi Xue Za Zhi; 2011 Feb; 91(6):375-81. PubMed ID: 21418908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of STAT3 signaling pathway by nitidine chloride suppressed the angiogenesis and growth of human gastric cancer.
    Chen J; Wang J; Lin L; He L; Wu Y; Zhang L; Yi Z; Chen Y; Pang X; Liu M
    Mol Cancer Ther; 2012 Feb; 11(2):277-87. PubMed ID: 22203730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of recombinant human GH on promoting tumor growth depend on the expression of GH receptor in vivo.
    Lin Y; Li S; Cao P; Cheng L; Quan M; Jiang S
    J Endocrinol; 2011 Dec; 211(3):249-56. PubMed ID: 21920991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CXCL1 gene silencing inhibits HGC803 cell migration and invasion and acts as an independent prognostic factor for poor survival in gastric cancer.
    Wang L; Zhang C; Xu J; Wu H; Peng J; Cai S; He Y
    Mol Med Rep; 2016 Nov; 14(5):4673-4679. PubMed ID: 27748927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. JAK2/STAT3 signaling pathway activation mediates tumor angiogenesis by upregulation of VEGF and bFGF in non-small-cell lung cancer.
    Zhao M; Gao FH; Wang JY; Liu F; Yuan HH; Zhang WY; Jiang B
    Lung Cancer; 2011 Sep; 73(3):366-74. PubMed ID: 21333372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [(-)-Epigallocatechin-3-gallate reduces vascular endothelial growth factor expression in gastric cancer cells via suppressing activity].
    Zhu BH; He YL; Zhan WH; Cai SR; Wang Z; Zhang CH; Chen HY
    Zhonghua Wei Chang Wai Ke Za Zhi; 2011 Aug; 14(8):631-5. PubMed ID: 21866460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CXCL1 from tumor-associated lymphatic endothelial cells drives gastric cancer cell into lymphatic system via activating integrin β1/FAK/AKT signaling.
    Wang Z; Wang Z; Li G; Wu H; Sun K; Chen J; Feng Y; Chen C; Cai S; Xu J; He Y
    Cancer Lett; 2017 Jan; 385():28-38. PubMed ID: 27832972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. (-)-Epigallocatechin-3-gallate inhibits growth of gastric cancer by reducing VEGF production and angiogenesis.
    Zhu BH; Zhan WH; Li ZR; Wang Z; He YL; Peng JS; Cai SR; Ma JP; Zhang CH
    World J Gastroenterol; 2007 Feb; 13(8):1162-9. PubMed ID: 17451194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD24 mediates gastric carcinogenesis and promotes gastric cancer progression via STAT3 activation.
    Wang YC; Wang JL; Kong X; Sun TT; Chen HY; Hong J; Fang JY
    Apoptosis; 2014 Apr; 19(4):643-56. PubMed ID: 24327257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Astragalus extract inhibits proliferation but enhances apoptosis in gastric cancer.
    Wang Z; Dong L; Zhen Y; Wang Y; Qi D; Xu A; Meng X; Li W
    Pak J Pharm Sci; 2016 Sep; 29(5):1473-1482. PubMed ID: 27731799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The expression and clinical significance of pSTAT3, VEGF and VEGF-C in pancreatic adenocarcinoma.
    Huang C; Huang R; Chang W; Jiang T; Huang K; Cao J; Sun X; Qiu Z
    Neoplasma; 2012; 59(1):52-61. PubMed ID: 22082308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A hypoxia-independent up-regulation of hypoxia-inducible factor-1 by AKT contributes to angiogenesis in human gastric cancer.
    Lee BL; Kim WH; Jung J; Cho SJ; Park JW; Kim J; Chung HY; Chang MS; Nam SY
    Carcinogenesis; 2008 Jan; 29(1):44-51. PubMed ID: 17984117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. STAT3-targeting RNA interference inhibits pancreatic cancer angiogenesis in vitro and in vivo.
    Huang C; Jiang T; Zhu L; Liu J; Cao J; Huang KJ; Qiu ZJ
    Int J Oncol; 2011 Jun; 38(6):1637-44. PubMed ID: 21479358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. VEGF promotes gastric cancer development by upregulating CRMP4.
    Chen S; Zhang X; Peng J; Zhai E; He Y; Wu H; Chen C; Ma J; Wang Z; Cai S
    Oncotarget; 2016 Mar; 7(13):17074-86. PubMed ID: 26934554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lentivirus-mediated siRNA targeting VEGF inhibits gastric cancer growth in vivo.
    Sun P; Yu H; Zhang WQ; Hu M; Lv R
    Oncol Rep; 2012 Nov; 28(5):1687-92. PubMed ID: 22895814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.